Cargando…

Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor

Sitagliptin (SG) increases serum GLP-1 (Glucagon-like peptide-1) through inhibition of the hormone degradation. Resistant starch (RS) induces GLP-1 expression by stimulating L-cells in the intestine. Sitagliptin and resistant starch may have a synergistic interaction in the induction of GLP-1. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldsmith, Felicia, Keenan, Michael J., Raggio, Anne M., Ye, Xin, Hao, Zheng, Durham, Holiday, Geaghan, James, Jia, Weiping, Martin, Roy J., Ye, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418617/ https://www.ncbi.nlm.nih.gov/pubmed/25938560 http://dx.doi.org/10.1371/journal.pone.0126177

Ejemplares similares

Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice
por: Gao, Zhanguo, et al.
Publicado: (2009)

Regulation of microbiota—GLP1 axis by sennoside A in diet-induced obese mice
por: Le, Jiamei, et al.
Publicado: (2019)

The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers
por: Tan, Tricia, et al.
Publicado: (2017)

Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling
por: Remm, Friederike, et al.
Publicado: (2018)

Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 Tachyphylaxis
por: Meguro, Shu, et al.
Publicado: (2014)

Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice
por: Sun, Yongning, et al.
Publicado: (2018)

Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
por: Stolar, Mark W, et al.
Publicado: (2013)

Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice
por: Tomas, Eva, et al.
Publicado: (2015)

Correction: Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

Correction: Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
Publicado: (2014)

From the past to future: from energy expenditure to energy intake to energy expenditure
por: Müller, M J, et al.
Publicado: (2017)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

OR05-6 The Effect of the GLP1R Variant rs6923761 on Post-Prandial Glucose Levels during Treatment with Sitagliptin
por: Mashayekhi, Mona, et al.
Publicado: (2019)

A Physiologically‐Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP‐1 and GIP and the DPP4 Inhibitor Sitagliptin
por: Balazki, Pavel, et al.
Publicado: (2020)

Erratum: From the past to future: from energy expenditure to energy intake to energy expenditure
por: Müller, M J, et al.
Publicado: (2017)

Comparison of GLP-1 Analogues versus Sitagliptin in the Management of Type 2 Diabetes: Systematic Review and Meta-Analysis of Head-to-Head Studies
por: Wang, Tiansheng, et al.
Publicado: (2014)

Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
por: Watanabe, Mitsuhiro, et al.
Publicado: (2012)

Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking
por: Ramírez, E., et al.
Publicado: (2018)

Sitagliptin improves functional recovery via GLP‐1R‐induced anti‐apoptosis and facilitation of axonal regeneration after spinal cord injury
por: Han, Wen, et al.
Publicado: (2020)

Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists: A meta-analysis
por: Dai, Danping, et al.
Publicado: (2019)

Sitagliptin-induced hemolysis
por: Bekur, Ragini, et al.
Publicado: (2010)

Sitagliptin-Associated Angioedema
por: Gosmanov, Aidar R., et al.
Publicado: (2012)

What Is the Impact of Energy Expenditure on Energy Intake?
por: Bosy-Westphal, Anja, et al.
Publicado: (2021)

Energy expenditure in caving
por: Antoni, Giorgia, et al.
Publicado: (2017)

Sennoside A Induces GLP-1 Secretion Through Activation of the ERK1/2 Pathway in L-Cells
por: Ma, Li, et al.
Publicado: (2020)

Estimating Energy Expenditure from Heart Rate in Older Adults: A Case for Calibration
por: Schrack, Jennifer A., et al.
Publicado: (2014)

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
por: Cho, Yong Kyun
Publicado: (2018)

Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin
por: Narimani, Rouhollah, et al.
Publicado: (2021)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

Energy expenditure of interruptions to sedentary behavior
por: Swartz, Ann M, et al.
Publicado: (2011)

Fixed drug eruption to sitagliptin
por: Gupta, Mrinal, et al.
Publicado: (2015)

Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes
por: Shankar, R Ravi, et al.
Publicado: (2016)

Energy expenditure during overfeeding
por: Joosen, Annemiek MCP, et al.
Publicado: (2006)

Correction: Energy expenditure in caving
por: Antoni, Giorgia, et al.
Publicado: (2018)

Glucagon Regulation of Energy Expenditure
por: Kleinert, Maximilian, et al.
Publicado: (2019)

Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
por: Sayari, Saba, et al.
Publicado: (2018)

Increased Lipolysis and Energy Expenditure in a Mouse Model with Severely Impaired Glucagon Secretion
por: Lou, Phing-How, et al.
Publicado: (2011)

Postprandial energy expenditure in whole-food and processed-food meals: implications for daily energy expenditure
por: Barr, Sadie B., et al.
Publicado: (2010)

Physical Activity Energy Expenditure and Total Daily Energy Expenditure in Successful Weight Loss Maintainers
por: Ostendorf, Danielle M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p4ll3j3298ohovs38ar1neqcov